Analyzing Spatial Heterogeneity in DCE- and DW-MRI Parametric Maps to Optimize Prediction of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer.
about
Multi-site clinical evaluation of DW-MRI as a treatment response metric for breast cancer patients undergoing neoadjuvant chemotherapyIdentifying MRI markers associated with early response following laser ablation for neurological disorders: preliminary findings.Correlation of tumor characteristics derived from DCE-MRI and DW-MRI with histology in murine models of breast cancerEarly Prediction and Evaluation of Breast Cancer Response to Neoadjuvant Chemotherapy Using Quantitative DCE-MRI.Predicting the Response of Breast Cancer to Neoadjuvant Therapy Using a Mechanically Coupled Reaction-Diffusion Model.DCE-MRI Texture Features for Early Prediction of Breast Cancer Therapy ResponseThree-dimensional Image-based Mechanical Modeling for Predicting the Response of Breast Cancer to Neoadjuvant Therapy.Heterogeneous drug penetrance of veliparib and carboplatin measured in triple negative breast tumors.Chemotherapy-Response Monitoring of Breast Cancer Patients Using Quantitative Ultrasound-Based Intra-Tumour HeterogeneitiesThe effects of intravoxel contrast agent diffusion on the analysis of DCE-MRI data in realistic tissue domains.Imaging Considerations and Interprofessional Opportunities in the Care of Breast Cancer Patients in the Neoadjuvant Setting.Combining multiparametric MRI with receptor information to optimize prediction of pathologic response to neoadjuvant therapy in breast cancer: preliminary results.Early detection of chemotherapy-refractory patients by monitoring textural alterations in diffuse optical spectroscopic images.
P2860
Q35224703-598FF821-3050-4A2F-ABCD-0DF8CC1B5B13Q35517507-ADC9F8CE-688C-48E9-AC69-2D30C01DD9A1Q35762255-00DE4774-6028-479B-B61D-263D9DFD4A0FQ35947118-9049C7AF-1791-4FFC-9145-A1312DF4AD00Q36296828-07EFEF5F-1B1C-4334-8ADE-986D9EE800CDQ38687135-3D565C8A-D1F2-4E47-A77D-8A8933FB4FD1Q39044851-8A32CA12-969E-4184-B0E8-072F9F9D8B72Q41276800-CAB7C2C6-204A-449B-AF2C-88A5DE3BE5ABQ41606810-0C79B708-6532-48AB-85D2-F9A68740C8BFQ47370345-8EDC1B0C-4F7D-476F-B4D5-7F5610ACD6FFQ47959144-1FF0B3BA-0F4A-47E2-A5C6-F178A76F32E0Q48265826-19A89885-6D14-419A-8677-6DB254BAB8CAQ50782447-31A636F3-095F-4543-A6A6-4B8B90D602A7
P2860
Analyzing Spatial Heterogeneity in DCE- and DW-MRI Parametric Maps to Optimize Prediction of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Analyzing Spatial Heterogeneit ...... Chemotherapy in Breast Cancer.
@en
Analyzing Spatial Heterogeneit ...... Chemotherapy in Breast Cancer.
@nl
type
label
Analyzing Spatial Heterogeneit ...... Chemotherapy in Breast Cancer.
@en
Analyzing Spatial Heterogeneit ...... Chemotherapy in Breast Cancer.
@nl
prefLabel
Analyzing Spatial Heterogeneit ...... Chemotherapy in Breast Cancer.
@en
Analyzing Spatial Heterogeneit ...... Chemotherapy in Breast Cancer.
@nl
P2093
P2860
P356
P1476
Analyzing Spatial Heterogeneit ...... Chemotherapy in Breast Cancer.
@en
P2093
A Bapsi Chakravarthy
Hakmook Kang
Jaime Farley
Lori R Arlinghaus
Melinda Sanders
Richard G Abramson
Thomas E Yankeelov
Vandana G Abramson
P2860
P356
10.1593/TLO.13748
P577
2014-02-01T00:00:00Z